Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Process for the manufacture of (E)-4-N,N-dialkylamino crotonic acid in HX salt form and use thereof for synthesis of EGFR tyrosine kinase inhibitors

Process for the manufacture of (E)-4-N,N-dialkylamino crotonic acid in HX salt form and use thereof for synthesis of EGFR tyrosine kinase inhibitors

US Patent 9242965 · Granted Jan 26, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods and compounds useful in the synthesis of an AAK1 inhibitor2025
Black metallic nanorod arrays and method of manufacturing thereof2024
Prodrug of pyrrolidone derivatives as glucokinase activator2024
Process and intermediates for the preparation of certain nematicidal sulfonamide2024
Process and intermediates for the preparation of certain nematicidal sulfonamide2022
Liquid separation device comprising a metallic mesh with a hydrophobic polymer c2020
Multifunctional dyeing and finishing kettle and industrialized supercritical CO22020
System for anhydrous boiling, bleaching and dyeing using supercritical carbon di2020
Dye for dyeing cotton fiber in supercritical carbon dioxide, preparation method 2020
Supercritical fluid dyeing and finishing system and method2020
Centrifugation-assisted preparation of additive-free carbon-decorated magnetite 2019
Process for the manufacture of 4-aminobenzoamidine dihydrochloride2019